Elon Musk's Neuralink announced that they received approval to begin recruitment for their first-in-human clinical trial. The PRIME Study (short for Precise Robotically Implanted Brain-Computer Interface) – a groundbreaking investigational medical device trial for their fully-implantable, wireless brain-computer interface (BCI) – aims to evaluate the safety of their implant (N1) and surgical robot (R1) and assess the initial functionality of their BCI for enabling people with paralysis to control external devices with their thoughts.
News Source: [ Ссылка ]
Emerging Technologies eBook [ Ссылка ]
Join this channel to get access to perks:
[ Ссылка ]
Opportunity to convert Your Idea into Online Business [ Ссылка ]
